Coronavirus: dermatology update
In response to the coronavirus (COVID-19) outbreak, please read our advice and information.
We have a translational and clinical research portfolio and are developing a focus on treatment options in hidradentitis suppurativa. We are a site for clinical trials developing novel therapies and assessing the effectiveness of established treatments. We are also involved with studies assessing the impact hidradentitis suppurativa has on patient quality of life, specifically looking at anxiety and depression and correlating these scores with clinical severity scores.
Find out more about our open and completed clinical trials.